Key result
Enalaprilat and L-158,809 significantly improved load-sensitive left ventricular relaxation abnormalities in dogs with pressure-overloaded left ventricular hypertrophy.
Why the study?
Does enalaprilat or L-158,809 improve left ventricular diastolic relaxation in dogs with left ventricular hypertrophy?
Does enalaprilat or L-158,809 improve left ventricular diastolic relaxation in dogs with left ventricular hypertrophy?
Angiotensin-converting enzyme inhibitors and angiotensin II type-1 receptor antagonists improve load-sensitive diastolic relaxation abnormalities in a canine model of hypertensive left ventricular hypertrophy.
Answers are grounded in this paper and cite their sources.
Should not yet influence clinical management of human LVH; leaves open translation of ACEI/ARB effects on diastolic relaxation.
We studied effects of enalaprilat and L-158,809, an angiotensin II type-1 receptor antagonist, on left ventricular (LV) diastolic relaxation in 11 normal control dogs and 16 LV hypertrophied (LVH) dogs with perinephritic hypertension. At baseline, LV systolic and end-diastolic pressures and end-systolic elastance were increased in the LVH group (all P < 0.01 vs. the control group). LV relaxation time constant was also prolonged (P < 0.01), suggesting impaired LV diastolic relaxation in this model of LVH. Before and after the administration of enalaprilat (0.25 mg/kg) and L-158,809 (0.30 mg/kg), LV relaxation was assessed over a wide range of LV loading conditions during vena caval occlusion. LV relaxation time constant was insensitive to load reduction in the control group, which was not affected by enalaprilat or L-158,809. In contrast, LV unloading caused a significant prolongation of the relaxation time constant in the LVH group. This load-sensitive LV relaxation abnormality was significantly improved by enalaprilat or L-158,809. These results support the concept that angiotensin II is involved in the pathogenesis of diastolic dysfunction in pressure-overloaded LVH and also suggest that angiotensin-converting enzyme inhibitors and angiotensin II type-1 receptor antagonists are potentially beneficial in the treatment of the hypertrophied heart.
No takes yet. Share an insight, caveat, or question.
Hayashida et al. (1998) studied Left ventricular hypertrophy with perinephritic hypertension (n=27). Enalaprilat and L-158,809 vs. Normal control dogs and baseline was evaluated on Left ventricular relaxation time constant during load reduction. Enalaprilat and L-158,809 significantly improved load-sensitive left ventricular relaxation abnormalities in dogs with pressure-overloaded left ventricular hypertrophy.
Synapse has enriched 10 related papers. Consider them for comparative context: